Vectura specialises in the development of inhaled therapies, principally for the treatment of respiratory diseases.
Vectura develops products in-house and welcomes the opportunity to work in collaboration with partners, to out-license its products with larger markets to major pharmaceutical companies and to in-license molecules for development or co-development with partners.
Vectura also out-licenses its proprietary device and formulation technologies to other companies developing inhaled pharmaceuticals on a non-exclusive basis where the resulting license will generate significant value.
Please use this section of the website to investigate partnering opportunities with Vectura.